Literature DB >> 8813125

Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors.

M Sauter1, K Roemer, B Best, M Afting, S Schommer, G Seitz, M Hartmann, N Mueller-Lantzsch.   

Abstract

We report here that 85% of the patients with germ cell tumors (GCTs) produce antibodies directed against Env protein of human endogenous retroviruses. Individuals that received antitumor treatment showed a decrease with time in their antibody titers. Importantly, of the rare cases of non-GCT individuals with Env-antibodies (n= 15, 0.8%), none produced antibodies directed against the transmembrane domain (TM), whereas all tested Env-positive GCT patients (n= 49) generated such antibodies at high titers. TM is required for Env to be expressed at the cell surface. Thus, anti-TM antibodies constitute highly specific markers for GCT and may hint at a function of Env during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813125

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Chronic fatigue syndrome is not associated with expression of endogenous retroviral p15E.

Authors:  I H Gelman; E R Unger; A C Mawle; R Nisenbaum; W C Reeves
Journal:  Mol Diagn       Date:  2000-06

2.  Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X.

Authors:  Vivienne Armbruester; Marlies Sauter; Klaus Roemer; Barbara Best; Steffen Hahn; Achille Nty; Andreas Schmid; Stephan Philipp; Anja Mueller; Nikolaus Mueller-Lantzsch
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).

Authors:  Laurence Lavie; Milena Kitova; Esther Maldener; Eckart Meese; Jens Mayer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  An alternative approach to medical genetics based on modern evolutionary biology. Part 4: HERVs in cancer.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-11       Impact factor: 5.344

6.  Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications.

Authors:  H Roelofs; R J van Gurp; J W Oosterhuis; L H Looijenga
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

7.  HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.

Authors:  George R Young; Sandra N Terry; Lara Manganaro; Alvaro Cuesta-Dominguez; Gintaras Deikus; Dabeiba Bernal-Rubio; Laura Campisi; Ana Fernandez-Sesma; Robert Sebra; Viviana Simon; Lubbertus C F Mulder
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

8.  Human endogenous retrovirus K homologous sequences and their coding capacity in Old World primates.

Authors:  J Mayer; E Meese; N Mueller-Lantzsch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

10.  Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec.

Authors:  Alessia Ruggieri; Esther Maldener; Marlies Sauter; Nikolaus Mueller-Lantzsch; Eckart Meese; Oliver T Fackler; Jens Mayer
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.